Number of prescription rises but cost falls again

Number of prescription rises but cost falls again

Latest data from NHS Digital shows an increase in the number of prescription items dispensed in the community, but a drop in their cost to the NHS.

In 2018, 1.1 billion prescription items were handed out in the community setting, marking an increase of 0.3% (2.9 million) from 1.1 billion in 2017.

However, in the same year, the net ingredient cost (NIC) of prescriptions was £8.8 billion, a decrease of 3.7% (£336.6 million) from the £9.2 billion spent in 2017.

The top three treatments by NIC for 2018 were enteral nutrition (£2.64 billion), the corticosteroid beclometasone dipropionate (£2.38 billion) and the anticoagulant apixaban (£2.23 billion).

The number one drug for 2017, the corticosteroid fluticasone propionate, slipped to fourth place last year, with a NIC of £2.15 billion.

In 2017, the number of prescriptions rose 0.15% to 1.11 billion, while the NIC dipped 0.41% – or £37.6 million – from 2016 to £9.17 billion.

28th March 2019


Share this:
March 28, 2019 / Pharma News